Gloria Dalla Costa, M.Sc.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multiple Sclerosis | 25 | 2024 | 3250 | 3.510 |
Why?
|
Neurofilament Proteins | 6 | 2024 | 337 | 2.140 |
Why?
|
Demyelinating Diseases | 8 | 2024 | 358 | 2.020 |
Why?
|
Leukoencephalopathy, Progressive Multifocal | 3 | 2024 | 133 | 1.410 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 5 | 2020 | 558 | 1.140 |
Why?
|
Immunologic Factors | 4 | 2024 | 1597 | 0.950 |
Why?
|
JC Virus | 1 | 2024 | 87 | 0.900 |
Why?
|
Disabled Persons | 2 | 2023 | 1210 | 0.800 |
Why?
|
Infant Formula | 1 | 2019 | 195 | 0.580 |
Why?
|
Oligoclonal Bands | 2 | 2021 | 17 | 0.570 |
Why?
|
Walking | 5 | 2023 | 1201 | 0.490 |
Why?
|
Intermediate Filaments | 3 | 2020 | 171 | 0.470 |
Why?
|
Facial Hemiatrophy | 1 | 2013 | 24 | 0.420 |
Why?
|
Antibodies, Viral | 1 | 2024 | 3215 | 0.410 |
Why?
|
Myeloid Cells | 1 | 2017 | 840 | 0.410 |
Why?
|
Facial Pain | 1 | 2013 | 122 | 0.390 |
Why?
|
Professional Role | 1 | 2014 | 316 | 0.370 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 3 | 2024 | 256 | 0.370 |
Why?
|
Neurology | 2 | 2018 | 787 | 0.350 |
Why?
|
Cesarean Section | 1 | 2019 | 1426 | 0.340 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3118 | 0.250 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3241 | 0.250 |
Why?
|
Europe | 2 | 2020 | 3441 | 0.210 |
Why?
|
Clothing | 1 | 2020 | 96 | 0.170 |
Why?
|
Disease Progression | 6 | 2024 | 13674 | 0.160 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily B | 1 | 2019 | 85 | 0.160 |
Why?
|
Wireless Technology | 1 | 2020 | 102 | 0.160 |
Why?
|
Adult | 19 | 2024 | 223851 | 0.160 |
Why?
|
Safety-Based Drug Withdrawals | 1 | 2018 | 36 | 0.160 |
Why?
|
Humans | 39 | 2024 | 768970 | 0.150 |
Why?
|
Axons | 2 | 2024 | 1678 | 0.150 |
Why?
|
Search Engine | 1 | 2019 | 142 | 0.150 |
Why?
|
Optic Nerve | 1 | 2021 | 571 | 0.140 |
Why?
|
Immunosuppressive Agents | 3 | 2020 | 4207 | 0.140 |
Why?
|
Social Isolation | 1 | 2020 | 366 | 0.140 |
Why?
|
Guillain-Barre Syndrome | 1 | 2019 | 127 | 0.140 |
Why?
|
Middle Aged | 15 | 2024 | 223737 | 0.140 |
Why?
|
Disability Evaluation | 1 | 2023 | 1839 | 0.130 |
Why?
|
Female | 22 | 2024 | 397515 | 0.130 |
Why?
|
Postural Balance | 1 | 2020 | 639 | 0.120 |
Why?
|
Fatigue | 1 | 2022 | 1557 | 0.120 |
Why?
|
Superoxide Dismutase | 1 | 2017 | 595 | 0.120 |
Why?
|
Cell Polarity | 1 | 2017 | 639 | 0.120 |
Why?
|
Male | 17 | 2024 | 365203 | 0.110 |
Why?
|
Neurodegenerative Diseases | 1 | 2022 | 1094 | 0.110 |
Why?
|
Prognosis | 3 | 2020 | 30046 | 0.110 |
Why?
|
Seasons | 1 | 2019 | 1524 | 0.100 |
Why?
|
Motor Cortex | 1 | 2020 | 1014 | 0.100 |
Why?
|
Age of Onset | 1 | 2019 | 3346 | 0.100 |
Why?
|
Interleukin-1beta | 1 | 2017 | 1026 | 0.100 |
Why?
|
Immunomodulation | 1 | 2015 | 549 | 0.100 |
Why?
|
Receptors, Immunologic | 1 | 2017 | 1418 | 0.090 |
Why?
|
Data Collection | 1 | 2020 | 3324 | 0.090 |
Why?
|
Breast Feeding | 1 | 2019 | 1364 | 0.090 |
Why?
|
Gene Expression Profiling | 3 | 2024 | 9549 | 0.090 |
Why?
|
Fructose | 1 | 2012 | 284 | 0.090 |
Why?
|
Migraine with Aura | 1 | 2012 | 204 | 0.090 |
Why?
|
Pandemics | 2 | 2020 | 8749 | 0.090 |
Why?
|
Young Adult | 6 | 2021 | 60131 | 0.090 |
Why?
|
Migraine Disorders | 2 | 2013 | 1713 | 0.080 |
Why?
|
Statistics, Nonparametric | 1 | 2015 | 2862 | 0.080 |
Why?
|
Diagnostic Errors | 1 | 2017 | 1281 | 0.080 |
Why?
|
Nervous System Diseases | 1 | 2020 | 1665 | 0.080 |
Why?
|
Cohort Studies | 4 | 2019 | 41808 | 0.080 |
Why?
|
World Health Organization | 1 | 2014 | 1328 | 0.070 |
Why?
|
Patients | 1 | 2014 | 908 | 0.070 |
Why?
|
Follow-Up Studies | 3 | 2019 | 39394 | 0.070 |
Why?
|
Analysis of Variance | 1 | 2015 | 6236 | 0.070 |
Why?
|
Membrane Glycoproteins | 1 | 2017 | 3713 | 0.070 |
Why?
|
Italy | 2 | 2020 | 856 | 0.060 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 4651 | 0.060 |
Why?
|
Vitamins | 1 | 2013 | 1638 | 0.060 |
Why?
|
Research Design | 1 | 2020 | 6214 | 0.060 |
Why?
|
Inflammation | 2 | 2021 | 10868 | 0.060 |
Why?
|
Longitudinal Studies | 1 | 2020 | 14794 | 0.060 |
Why?
|
Vitamin D Deficiency | 1 | 2013 | 1388 | 0.050 |
Why?
|
Quality of Life | 2 | 2022 | 13510 | 0.050 |
Why?
|
Brain | 4 | 2021 | 27453 | 0.050 |
Why?
|
Prevalence | 1 | 2020 | 15879 | 0.050 |
Why?
|
Telemedicine | 1 | 2020 | 3110 | 0.050 |
Why?
|
Learning | 1 | 2012 | 1760 | 0.050 |
Why?
|
Social Conditions | 1 | 2022 | 121 | 0.050 |
Why?
|
Patient Selection | 1 | 2014 | 4265 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2020 | 10400 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 5 | 2024 | 36854 | 0.050 |
Why?
|
Physician-Patient Relations | 1 | 2014 | 3269 | 0.050 |
Why?
|
Communication | 1 | 2014 | 3908 | 0.040 |
Why?
|
Acceleration | 1 | 2020 | 190 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2017 | 22296 | 0.040 |
Why?
|
Vitamin D | 1 | 2013 | 3311 | 0.040 |
Why?
|
Pregnancy | 2 | 2019 | 30265 | 0.040 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily K | 1 | 2019 | 94 | 0.040 |
Why?
|
Receptors, CCR6 | 1 | 2019 | 73 | 0.040 |
Why?
|
Spain | 1 | 2020 | 485 | 0.040 |
Why?
|
Infant, Newborn | 1 | 2019 | 26428 | 0.040 |
Why?
|
Pyramidal Tracts | 1 | 2020 | 252 | 0.040 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2019 | 151 | 0.040 |
Why?
|
Denmark | 1 | 2020 | 776 | 0.040 |
Why?
|
Adolescent | 5 | 2021 | 89244 | 0.040 |
Why?
|
Evoked Potentials, Motor | 1 | 2020 | 465 | 0.040 |
Why?
|
Epilepsy | 1 | 2012 | 3326 | 0.030 |
Why?
|
Pain | 1 | 2012 | 5100 | 0.030 |
Why?
|
Infant | 1 | 2019 | 36556 | 0.030 |
Why?
|
Electronic Health Records | 1 | 2014 | 4879 | 0.030 |
Why?
|
Visual Pathways | 1 | 2021 | 559 | 0.030 |
Why?
|
Interferon-beta | 1 | 2018 | 349 | 0.030 |
Why?
|
Drug Substitution | 1 | 2018 | 291 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2021 | 1194 | 0.030 |
Why?
|
Time Factors | 1 | 2017 | 40261 | 0.030 |
Why?
|
Gadolinium | 1 | 2021 | 965 | 0.030 |
Why?
|
Retrospective Studies | 4 | 2021 | 81903 | 0.030 |
Why?
|
Netherlands | 1 | 2020 | 2277 | 0.030 |
Why?
|
Treatment Outcome | 3 | 2024 | 65480 | 0.030 |
Why?
|
Electromyography | 1 | 2020 | 1401 | 0.030 |
Why?
|
Hand | 1 | 2020 | 913 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2020 | 1855 | 0.030 |
Why?
|
Lymphocytes | 1 | 2021 | 2614 | 0.030 |
Why?
|
Monitoring, Physiologic | 1 | 2020 | 1798 | 0.030 |
Why?
|
Pain, Intractable | 1 | 2013 | 132 | 0.020 |
Why?
|
Accidental Falls | 1 | 2020 | 1080 | 0.020 |
Why?
|
Temperature | 1 | 2019 | 2235 | 0.020 |
Why?
|
Risk Factors | 2 | 2015 | 74976 | 0.020 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2020 | 1489 | 0.020 |
Why?
|
Neutrophils | 1 | 2021 | 3785 | 0.020 |
Why?
|
Tomography, Optical Coherence | 1 | 2021 | 2957 | 0.020 |
Why?
|
Gene Expression | 1 | 2020 | 7603 | 0.020 |
Why?
|
Contrast Media | 1 | 2021 | 5334 | 0.020 |
Why?
|
Peptides | 1 | 2018 | 4353 | 0.020 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2019 | 4056 | 0.010 |
Why?
|
Algorithms | 1 | 2024 | 14201 | 0.010 |
Why?
|
Body Mass Index | 1 | 2020 | 13055 | 0.010 |
Why?
|
Recurrence | 1 | 2013 | 8513 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15471 | 0.010 |
Why?
|
Chronic Disease | 1 | 2013 | 9384 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2012 | 6673 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 59739 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2013 | 15951 | 0.010 |
Why?
|
Physicians | 1 | 2013 | 4607 | 0.010 |
Why?
|
United States | 1 | 2019 | 73186 | 0.010 |
Why?
|
Aged | 1 | 2020 | 171786 | 0.000 |
Why?
|